Share markets in India are trading on a positive note. Benchmark indices rallied over 1% today tracking massive buying momentum in Asian peers and foreign fund inflows.
Asian share markets scaled four-month peaks as investors counted on fiscal stimulus to sustain the global economic recovery, even as surging coronavirus cases delayed re-openings across the United States.
The BSE Sensex is trading up by 468 points, up 1.3%, at 36,500 levels. Meanwhile, the NSE Nifty is trading up by 160 points.
The BSE Mid Cap index is trading up by 1%. The BSE Small Cap index is trading up by 1.2%.
On the sectoral front, gains are largely seen in the energy sector and banking sector.
The rupee is trading at 74.66 against the US$.
Gold prices are trading down by 0.3% at Rs 47,922 per 10 grams.
Speaking of the current stock market scenario, investors and traders who are new to stock markets have had a superb experience over past three months as almost any and every stock has given them phenomenal returns.
Moving on, market participants are tracking Reliance Industries' share price. Shares of the company hit a fresh record high of Rs 1840 after the company bagged 12th foreign investment for its digital arm Jio Platforms on Friday.
The company's market capitalization breached the Rs 11.5 trillion mark in early trade today. The company had breached the Rs 11 trillion mark on June 19 when it announced that it has become net-debt free well ahead of its deadline of March 2021.
In the past two months, Jio has raised Rs 1.17 trillion through stake sales to ramp up its digital services business and expedite its debt reduction goals.
In news from the realty sector, Sobha and Oberoi Realty are among the top buzzing stocks today.
Shares of the company surged over 4% today after it issued an operational update for the first quarter of the financial year 2020-21.
The company clocked a 70% jump in sales volume during Q1FY21 as compared to Q4FY20.
The company posted its highest-ever income, sales volume and collections during FY20 despite challenges thrown by Covid-19 during last fortnight of the fourth quarter.
In an exchange filing, the company said that demand remained consistent despite pandemic-related uncertainties. The company managed to reduce net debt and average interest cost of borrowing during the quarter.
The company has reported a 5% decline in its consolidated net profit at Rs 2.8 billion for the fiscal year 2019-20 despite higher income and strong sales bookings of Rs 28.8 billion. Its net profit stood at Rs 3 billion in the financial year 2018-19.
However, the company's total income rose to Rs 38.3 billion in 2019-20 from Rs 35.2 billion in the preceding fiscal.
Global research firm CLSA has maintained an outperform call on the stock with a target of Rs 252 per share. Research firm Jefferies also has a buy rating on the stock.
Sobha share price is presently trading up by 5%.
Moving on, in the latest developments from the IPO space, India witnessed four initial public offerings (IPOs) worth US$ 2.08 million in the three months ended June 2020 as the coronavirus pandemic impacted economic activities, according to an EY India report.
All the IPOs were in the Small and Medium Enterprises (SMEs) segment and the median deal size was US$ 0.38 million.
In the SME market, there were four IPOs verses 14 and 11 in Q2 2019 and Q1 2020, respectively.
About the April-June period, the report said that consumer products & retail, and diversified industrial products were the active sectors in terms of the number of IPOs. Each sector had two IPOs on the SME market and they were worth around US$ 2.08 million.
Laxmi Goldorna House, Nirmitee Robotics India, Ballwin Industries and DJ Mediapoint & Logistics came out with their IPOs during the June quarter.
In other news, Mumbai-based specialty chemicals maker Rossari Biotech is preparing to debut on the stock exchanges, potentially ending the over 3-month IPO interruption triggered by the coronavirus lockdown.
SBI Cards & Payment Services was the last company to list in March 2020.
Reports state that business has boomed for Rossari Biotech during the Covid-19 phase due to rising demand for disinfectants and sanitizers manufactured by the firm.
Post the final approval from markets regulator for revised documents with updated financials, the plan is to launch the IPO in a few weeks by mid or end July.
Reportedly, the total size of the IPO is likely to be around Rs 3 billion and it will be a mix of primary and secondary issues of shares.
This can be seen in the chart below:
Are Retail Investors Back in the IPO Game?
Comments
Log in or sign up to join the conversation.